The diagnostic and prognostic significance of SCUBE1 levels in Crimean-Congo hemorrhagic fever

International Journal of Infectious Diseases

Volumn 17, Issue 11, 2013, Pages e1042-e1045

  Menteşe, Ahmet ^a   Yilmaz, Gürdal ^a   Sümer, Ayşegül ^a   Arslan, Mustafa ^a   Karahan, Süleyman Caner ^a   Köksal, Iftihar ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Biomarker; CCHF; Hemorrhagic fever; Prognostic significance; SCUBE1

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATINE KINASE; MEMBRANE PROTEIN; MYOGLOBIN; SIGNAL PEPTIDE CUB EGF DOMAIN CONTAINING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; CRIMEAN CONGO HEMORRHAGIC FEVER; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HEADACHE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYALGIA; NAUSEA; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; VOMITING;

BIOMARKER; CCHF; HEMORRHAGIC FEVER; PROGNOSTIC SIGNIFICANCE; SCUBE1;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84885386497     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.03.014     Document Type: Article

References (13)

1. Tu C.F., Yan Y.T., Wu S.Y., Djoko B., Tsai M.T., Cheng C.J., et al. Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1. J Biol Chem 2008, 283:12478-12488.
2. Tu C.F., Su Y.H., Huang Y.N., Tsai M.T., Li L.T., Chen Y.L., et al. Localization and characterization of a novel secreted protein SCUBE1 in human platelets. Cardiovasc Res 2006, 71:486-495.
3. Dai D.F., Thajeb P., Tu C.F., Chiang F.T., Chen C.H., Yang R.B., et al. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J Am Coll Cardiol 2008, 51:2173-2180.
4. Whitehouse C.A. Crimean-Congo hemorrhagic fever. Antivir Res 2004, 64:144-160.
5. Aidaros H. Public and animal health importance of Crimean-Congo haemorrhagic fever and other tick-transmitted diseases. WHO Mediterr Zoon Control Cnt 2003, 56:6-8.
6. Ergonul O., Celikbas A., Baykam N., Eren S., Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect 2006, 12:551-554.
7. Gunaydin N.S., Aydin K., Yilmaz G., Caylan R., Koksal I. Crimean-Congo hemorrhagic fever cases in Eastern Black Sea Region of Turkey: demographic, geographic, climatic, and clinical characteristics. Turk J Med Sci 2010, 40:829-834.
8. Yang R.B., Ng C.K., Wasserman S.M., Colman S.D., Shenoy S., Mehraban F., et al. Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem 2002, 277:46364-46373.
9. Lindemann S., Gawaz M. SCUBE1 a new scoop in vascular biology?. Cardiovasc Res 2006, 71:414-415.
10. Mentese A., Fidan E., Sumer A.U., Karahan S.C., Sonmez M., Altay D.U., et al. Is SCUBE 1 a new biomarker for gastric cancer?. Cancer Biomark 2012, 11:191-195.
11. Ulusoy S., Ozkan G., Menteşe A., Yavuz A., Karahan S.C., Sümer A.U. Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) level in hemodialysis patients and parameters affecting that level. Clin Biochem 2012, 45:1444-1449.
12. Yilmaz G., Koksal I., Topbas M., Yilmaz H., Aksoy F. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria. J Clin Virol 2010, 47:361-365.
13. Gonen I. Clinical and laboratory findings of patients with Crimean-Congo hemorrhagic fever in the emergency department at hospital admission. J Microbiol Infect Dis 2011, 1:1-4.